PREOP: Patient Preparedness for Pelvic Organ Prolapse Surgery

Sponsor
University of Pittsburgh (Other)
Overall Status
Completed
CT.gov ID
NCT03836365
Collaborator
University of Pittsburgh Medical Center (Other)
120
1
2
13
9.2

Study Details

Study Description

Brief Summary

Patient preparedness has been associated with increased patient satisfaction, decreased postoperative pain and decreased postoperative narcotic use; however, little is known regarding the optimal way to prepare patients prior to pelvic reconstructive surgery. The primary aim of this study is to determine if a preoperative counseling in person visit has similar rates of patient preparedness as a preoperative counseling phone call for women undergoing same-day pelvic organ prolapse surgery. Secondary aims evaluate patient satisfaction, postoperative pain scores and postoperative narcotic usage. Women who plan to undergo pelvic organ prolapse surgery will be randomized to a preoperative in person counseling visit or a preoperative counseling phone call. Participants will complete questionnaires to assess their preparedness, satisfaction and postoperative pain. The goal of this study is to gather information that will allow clinicians to improve patient surgical preparedness and satisfaction.

Condition or Disease Intervention/Treatment Phase
  • Other: Preoperative counseling office visit
  • Other: Preoperative counseling phone call
N/A

Detailed Description

This will be a randomized controlled trial to assess patient preparedness following a preoperative counseling in person visit when compared to a preoperative counseling phone call.

Recruitment & Enrollment: Participants will be recruited and enrolled from the urogynecology office during their surgical planning visit. The study will be introduced at this visit and participants will have the opportunity to bring the consent home to review and consider their participation prior to signing.

Randomization: Participants will be block randomized in a 1:1 ratio in block size of 2. Randomization will be done by REDCap. The participant will not be blinded given the nature of the intervention. Additionally, the attending surgeon, fellow and office staff (advanced practice providers, research staff, medical assistants) will be aware of the randomization group as they will be participating in the preoperative intervention or perioperative clinical care.

Intervention: Both the preoperative counseling visit and preoperative phone call will contain the same components of discussion and counseling which include surgical details, risks and benefits, preoperative and postoperative instructions and expectations. The visit will take place in the urogynecology office and the visits and phone calls will be done by either a fellow or advanced practice provider, all of whom have extensive experience with the standardized preoperative visit.

Follow up: A postoperative phone call will be completed either POD#1 or POD#2 to remind the participant to complete their daily pain diary. Each participant will follow up for their standard postoperative visit approximately 4-6 weeks postoperative. All patients routinely receive a call on POD#1 from our nurses to assess how they are doing postoperatively. This phone call will continue unchanged for all participants.

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Patient Preparedness for Pelvic Organ Prolapse Surgery: A Randomized Controlled Trial of Preoperative Counseling
Actual Study Start Date :
Apr 2, 2019
Actual Primary Completion Date :
May 1, 2020
Actual Study Completion Date :
May 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Preoperative counseling office visit

Participants will present for an in-person preoperative counseling office visit (preoperative counseling session). This will occur within a few weeks of surgery. Preoperative counseling topics are standardized and will be identical with each arm.

Other: Preoperative counseling office visit
All patients undergo a preoperative counseling session prior to surgery. Participants in this arm will have an in person preoperative counseling office visit.
Other Names:
  • Office
  • Active Comparator: Preoperative counseling phone call

    Participants will receive a preoperative counseling phone call (preoperative counseling session). This will occur within a few weeks of surgery. Preoperative counseling topics are standardized and will be identical with each arm.

    Other: Preoperative counseling phone call
    All patients undergo a preoperative counseling session prior to surgery. Participants in this arm will have a preoperative counseling phone call.
    Other Names:
  • Call
  • Outcome Measures

    Primary Outcome Measures

    1. Patient preparedness [At postoperative visit (about 4-6 weeks after surgery)]

      The percent of patients reporting preparedness on Preoperative Preparedness Questionnaire. Participants who answer "strongly agree" or "agree" to the statement "Overall, I felt prepared for my surgery" will be considered prepared. This instrument is a 9-item questionnaire and scored on a 5-point Likert scale with answers ranging from "5=strongly disagree" to "1=strongly agree" with "3=neutral." Therefore, scores of "1=strongly agree" or "2=agree" will be considered a positive answer for preparedness. It was adopted from a study by Kenton et al in 2007.

    Secondary Outcome Measures

    1. Patient satisfaction: Decision Scale-Pelvic Floor Disorders questionnaire [At postoperative visit (about 4-6 weeks after surgery)]

      The percent of patients reporting satisfaction on the Satisfaction with Decision Scale-Pelvic Floor Disorders questionnaire. This is a validated, 5-item questionnaire with answers on a 5-point likert scale with "1=strongly agree," "3=neutral" and "5=strongly disagree." Answers of "1=strongly agree" or "2=agree" to the statement "I am satisfied with my decision" will be considered satisfied.

    2. Postoperative pain scores [Postoperative days #1-7]

      Postoperative pain scores on postoperative days #1-7 on a scale of 0-10. Participants will complete a daily pain diary which will assess their pain score with 0=no pain and 10=worst pain imaginable.

    3. Postoperative narcotic use [Postoperative days #1-7]

      Postoperative narcotics used which will be assessed by the daily pain diary (question: "How many narcotic pills did you use today?" with the answer being the number of pills used that day).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years to 99 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Women planning to undergo same-day surgery to correct pelvic organ prolapse by the University of Pittsburgh Division of Urogynecology. Women remain eligible if they are admitted for observation following their surgery.
    Exclusion Criteria:
    • Non-English speaking patients

    • A preoperative exam requirement that would necessitate an in person office visit (i.e. need for pessary removal, self-catheterization teaching)

    • Plan for concomitant surgical management with gynecology oncology or colorectal surgery

    • Residence in a nursing home

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Magee-Womens' Hospital of UPMC Pittsburgh Pennsylvania United States 15213

    Sponsors and Collaborators

    • University of Pittsburgh
    • University of Pittsburgh Medical Center

    Investigators

    • Principal Investigator: Jessica Sassani, University of Pittsburgh

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Jessica Sassani, Fellow, Division of Female Pelvic Medicine & Reconstructive Surgery, University of Pittsburgh
    ClinicalTrials.gov Identifier:
    NCT03836365
    Other Study ID Numbers:
    • STUDY19010073
    First Posted:
    Feb 11, 2019
    Last Update Posted:
    Jun 4, 2020
    Last Verified:
    Jun 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jessica Sassani, Fellow, Division of Female Pelvic Medicine & Reconstructive Surgery, University of Pittsburgh
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 4, 2020